Close Server: KOPWWW05 | Not logged in


Welcome to Health Care POV | sign in | join

BROWSE BY TAGS

ADVANCE Perspective: Respiratory Views

Medicated Millennials
April 6, 2016 1:13 PM by ADVANCE for Respiratory Care & Sleep Medicine
By Tamer Abouras In spite of the fact that professional writing has increasingly moved to a digital medium, there is nonetheless an almost endless amount of ink (figuratively speaking) spent describing the “millennial” generation. Whether it’s their effect Read More...
0 comments »     
The Inhaler Hacking Arms Race
December 4, 2015 8:02 AM by ADVANCE for Respiratory Care & Sleep Medicine
By Tamer Abouras There are many, many blog entries and articles written daily which begin something like this: “There’s no getting around the fact that we’re currently living in the age of … [insert modern buzzword here].” Probably everyone is guilty Read More...
0 comments »     
CVS Funds Smoking Cessation Program for Veterans, Others
May 28, 2015 9:15 AM by ADVANCE for Respiratory Care & Sleep Medicine
Easter Seals is marking World No Tobacco Day on May 31, by launching a national smoking cessation program to help veterans, people with disabilities and caregivers live healthier, tobacco-free lives. Funding for the new program is supported by a $400,000 Read More...
0 comments »     
Improving Aerosol Therapy for Respiratory Disorders
May 1, 2015 9:15 AM by ADVANCE for Respiratory Care & Sleep Medicine
Premier healthcare innovation marketplace, Edison Nation Medical, and the American Association for Respiratory Care (AARC), have announced a global search to uncover innovations for improving aerosol therapy for patients with respiratory disorders. Inhaled Read More...
0 comments »     
FDA Pulls Unapproved Cold and Allergy Drugs; AAAAI Weighs In
March 3, 2011 11:07 AM by Valerie Newitt
The U.S. Food and Drug Administration announced March 2 that they are requiring the removal of unapproved prescription cold, oral cough and allergy products from the market, ranging from Accuhist DM to Zotex tablets in an A-to-Z banishment of hundreds Read More...
0 comments »     
Study Looks at Efficacy and Safety of Omalizumab
May 19, 2010 4:53 PM by Sharlene George
A late-breaking clinical abstract presented at the American Thoracic Society International Conference in New Orleans May 18 demonstrated that omalizumab (Xolair®, Novartis and Genentech) reduced the rate of asthma exacerbations by 25 percent in high-risk Read More...
1 comments »     
FDA Says LABAs Shouldn't Be Used Alone to Treat Asthma
February 22, 2010 8:22 AM by Colleen Mullarkey
Long-acting beta agonists should never be used alone in the treatment of asthma in children or adults, the FDA announced yesterday . Manufacturers must now include this warning on product labeling and take other steps to reduce the overall use of these Read More...
1 comments »     
Discovery May Yield New Asthma Therapy
August 14, 2009 2:12 PM by Vern Enge
Aldose reductase is not a term frequently bandied about in respiratory therapy departments today, but file that term in your brain, therapists, because current studies show aldose reductase inhibitors might significantly reduce allergic reactions that Read More...
0 comments »     
Aisle 3: Asthma Treatment
June 23, 2009 12:38 PM by Colleen Mullarkey
Could the local Walgreen's or CVS become your asthma patients' first stop when they need an allergy shot or nebulizer treatment? It certainly seems like that's what the pharmacy giants are hoping . With retail sales floundering, outpatient medical care Read More...
0 comments »     
Tennis Star Loses Big after Straying from Asthma Guidelines
January 21, 2009 12:00 PM by Colleen Mullarkey
When clinicians don't follow the asthma guidelines, patients usually end up paying the price. But in Filippo Volandri's case, he's literally paying the price - $166,000 in fact - for not following the guidelines as an asthma patient, Sky Sports reported Read More...
0 comments »     
Patients; Doctors Weigh in On LABA Risk
December 11, 2008 11:20 AM by test test
A panel of 30 medical and scientific Food and Drug Administration advisors plans to vote today on whether the safety risks posed by long acting beta agonists outweigh the benefits to respiratory patients. But professional and patient organizations across Read More...
0 comments »     
ACAAI 2008: The Sunny Side of Genomics in Asthma
November 7, 2008 6:17 PM by Colleen Mullarkey
Seattle's rain clouds and overcast skies didn't stop presenters from offering a sunny outlook for genomics and personalized medicine in asthma at this morning's breakfast symposium, "Asthma at the Cutting Edge." Stephen Peters, MD, PhD, kicked off the Read More...
0 comments »     

Search

About this Blog

Keep Me Updated